Trovagene Inc (NASDAQ:TROV)

0.3181
Delayed Data
As of Feb 23
 +0.0081 / +2.61%
Today’s Change
0.24
Today|||52-Week Range
2.10
+3.45%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close0.31
Today’s open0.31
Day’s range0.31 - 0.32
Volume591,299
Average volume (3 months)1,512,511
Market cap$16.8M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-13.22%
Earnings growth (this year)+41.61%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+21.82%
P/E ratioNM
Price/Sales166.87
Price/Book0.49

Competitors

 Today’s
change
Today’s
% change
ONCSOncoSec Medical Inc+0.01+0.56%
MBOTMicrobot Medical Inc+0.01+1.28%
--BARD1 Life Sciences ...+0.00+33.33%
PTIProteostasis Therape...+0.06+2.05%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$381.1K
Annual profit (last year)-$39.2M
Net profit margin-10,287.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Bill Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts